Research Alliance Corporation IV (Nasdaq: RACD), a special purpose acquisition company sponsored by an affiliate of RA Capital Management, priced its $75 million initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share. The shares are expected to begin trading on the Nasdaq Capital Market under the ticker “RACD” on July 13, 2026, with closing anticipated on July 14, 2026, subject to customary conditions.
The company is a blank check entity formed to pursue a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, with an intended focus on healthcare and healthcare-related industries. Leerink Partners is acting as sole bookrunning manager, and multiple institutional investors participated. The SEC declared the registration statement effective on July 10, 2026.